Email Us

2024 Canadian Hemoglobinopathy Association Annual Conference and AGM

Bridging Care for Wellness in Hemoglobinopathies

Registration Coming Soon.

Save the Date!

The 2024 CanHaem Annual Meeting will be taking place Friday, September 20th and Saturday, September 21st, in Halifax, Nova Scotia.

The official hotel and venue for the 2024 CanHaem Annual Meeting is The Westin Nova Scotian, 1181 Hollis Street, Halifax, NS B3H 2P6.

CanHaem group rate:

  • The Westin Nova Scotian for 279 CAD – 329 CAD per night

The booking deadline is Tuesday, August 20, 2024.

**IMPORTANT** If your booking will include extra nights on either end of the conference block, please first click “check availability”, then click “Edit Stay Details”, click the dates you want, click done, click “update stay details” and select your room type.

Follow the link: Book your group rate for 2024 CanHaem Annual Meeting

You may also call the hotel reservations department directly at 1-866-761-3513.

Air Travel
Air Canada is the preferred airline for the 2024 CanHaem Annual Meeting, which will be held Friday, September 20, 2024, to Saturday, September 21, 2024.

This a promotion code for the convention product. To book a flight with your promotion code, access aircanada.com and enter your promotion code PMPVW2A1 in the Promotion Code Box.

Applicable Rules

  • The booking is to be made to the following city: Halifax, YHZ (CA)
  • The travel period begins Friday, September 13, 2024, and ends Saturday, September 28, 2024.
  • Travel is valid Monday, Tuesday, Wednesday, Thursday, Friday, Saturday, Sunday.
  • For North America’ 5% applies on standard fares, 10% on flex fares & higher. For International Travel’ 10% on standard fares & higher.

 

Call for Abstracts

The goal of the scientific session at the CanHaem annual meeting is to present novel Canadian research in the field of hemoglobinopathies.

Coming Soon

Eligibility criteria:

  • All health care providers are invited to submit their research in the field of hemoglobinopathies.
  • At least one of the authors must be a CanHaem member.
  • If none of the abstract authors is a CanHaem member, the abstract must be sponsored by a current CanHaem member.
  • Abstracts with a presenting author who is (a) an employee of publicly traded or privately held ineligible companies, or (b) owner of a privately held company, will not be considered for oral presentation.
  • Ineligible companies are those whose primary business is producing, marketing, re-selling, or distributing healthcare products used by or on patients. Examples of such companies can be found on the ACCME website.

Maximum word length: 350 words.

Abstracts will be selected by a scientific committee and judged on the clarity of the presentation, quality of the work, state of completion, novelty, and relevance to the field of hemoglobinopathies.